X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-05-24 | ESPR | Biotech Target N V | 10% | P - Purchase | $20.22 | +100,000 | 4,477,964 | +2% | +$2,021,620 | ||||||
2021-05-19 | ESPR | Biotech Target N V | 10% | P - Purchase | $20.37 | +200,000 | 4,377,964 | +5% | +$4,073,960 | ||||||
| M | 2021-05-05 | ESPR | Biotech Target N V | 10% | P - Purchase | $20.21 | +230,000 | 4,177,964 | +6% | +$4,648,482 | |||||
2020-11-03 | ESPR | Biotech Target N V | 10% | P - Purchase | $25.31 | +200,000 | 3,947,964 | +5% | +$5,062,120 | ||||||
2020-03-11 | ESPR | Mayleben Timothy M | Pres, CEO | P - Purchase | $43.00 | +2,500 | 111,998 | +2% | +$107,500 | ||||||
2020-02-28 | ESPR | Mayleben Timothy M | Pres, CEO | P - Purchase | $49.00 | +5,000 | 109,498 | +5% | +$245,000 | ||||||
2020-01-23 | ESPR | Biotech Target N V | 10% | P - Purchase | $52.12 | +20,000 | 3,747,964 | +1% | +$1,042,398 | ||||||
2019-11-06 | ESPR | Mayleben Timothy M | Pres, CEO | P - Purchase | $36.98 | +5,000 | 83,663 | +6% | +$184,900 | ||||||
2019-11-06 | ESPR | Biotech Target N V | 10% | P - Purchase | $37.30 | +75,000 | 3,727,964 | +2% | +$2,797,560 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |